Radio and PodcastRadio and PodcastLive Radio & Podcasts
EMERGENT-5: Cobenfy and Treatment Durability artwork
Health

EMERGENT-5: Cobenfy and Treatment Durability

Psychopharmacology and Psychiatry Updates by Psychopharmacology Institute

Sep 18, 202612:55Health

In this episode, we sit down with Dr. Oliver Freudenreich to unpack EMERGENT-5, the year-long trial tracking Cobenfy's real-world durability and safety in schizophrenia. We explore whether early symptom gains hold up ove...

Related Episodes

Continue listening to more episodes from Psychopharmacology and Psychiatry Updates.

Antipsychotics and Weight Gain

Sep 13, 2026 - 14:59

In this episode, we sit down with Dr. Oliver Freudenreich to unpack antipsychotic-induced weight gain — w...

AUD Medications and Hepatic Safety

Sep 3, 2026 - 10:14

In this episode, we explore how liver status shapes medication choice for alcohol use disorder. Dr. Kevin...